Pathogenesis and management of idiopathic myelofibrosis

Bailliere's Clinical Haematology

Volumn 11, Issue 4, 1998, Pages 751-767

  Reilly, J T ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Agnogenic myeloid metaplasia; Idiopathic myelofibrosis; Management; Pathogenesis

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; CALMODULIN; CLADRIBINE; DANAZOL; ERYTHROPOIETIN; HYDROXYUREA; INTERLEUKIN 1; OXYMETHOLONE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D DERIVATIVE;

ANEMIA; BONE MARROW TRANSPLANTATION; CELL HYPERPLASIA; CELL PROLIFERATION; CYTOKINE RELEASE; FLUID RETENTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HIRSUTISM; HUMAN; LIVER DYSFUNCTION; LIVER TUMOR; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; RADIOTHERAPY; REVIEW; SPLENECTOMY; STROMA CELL; SURVIVAL TIME;

EID: 0032323530     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(98)80037-1     Document Type: Article

References (113)

1. Aloe Spiriti MA Latagliata R Avvisati G Erythropoietin treatment of idiopathic myelofibrosis Haematologica 78 1993 371 373
2. Andersen RE Hoshino T Yamamoto T Myelofibrosis with myeloid metaplasia in survivors of the atomic bomb in Hiroshima Annals of Internal Medicine 60 1964 1 18
3. Anderson JE Sale G Appelbaum FR Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis British Journal of Haematology 98 1997 1010 1016
4. Asimakopoulos FA Green AR Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders British Journal of Haematology 95 1996 219 226
5. Barosi G New trends in the treatment of myelofibrosis with myeloid metaplasia Forum 3.1 1993 59 69
6. Barosi G Liberato LN Costa A Ascari E Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis and myeloid metaplasia Blut 58 1989 271 274
7. Barosi G Berzuini C Liberato A prognostic classification of myelofibrosis with myeloid metaplasia British Journal of Haematology 70 1988 397 401
8. Barosi G Ambrosetti A Buratti A Splenectomy for patients with myelofibrosis and metaplasia: pretreatment variables and outcome prediction Leukemia 7 1993 200 206
9. Barosi G Liberato LN Guarone R Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia British Journal of Haematology 83 1993 365 369
10. Bartlett RP Greipp PR Tefferi A Extramedullary hematopoiesis manifesting as a symptomatic pleural effusion Mayo Clinic Proceedings 70 1995 1161 1164
11. Benbassat J Gilon D Penchas S The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia American Journal of Hematology 33 1990 128 135
12. Bernabei PA Arcangeli A Casini M Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease British Journal of Haematology 63 1986 353 357
13. Besa EC Nowell PC Geller NL Gardner FH Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies predicting response and survival Cancer 49 1982 308 313
14. Le Bousse-Kerdilès MC Souyri M Smadja-Joffe F Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome Blood 79 1992 3179 3187
15. + haematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia Blood 88 1996 4534 4546
16. Burkhardt R Bartl R Beil E Myelofibrosis-osteosclerosis syndrome: review of literature in histomorphology Burkhardt R Bartl R Beil E Advances in the Biosciences 1974 Dahlem Workshop on Myelofibrosis-Osteosclerosis Syndrome Berlin 9 54
17. Buschle M Janssen JWG Drexler H Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterised by a N-ras gene mutation Leukemia 2 1988 658 660
18. Caen JP Dechamps JF Bodevin E Megakaryocytes and myelofibrosis in gray platelet syndrome Nouvelle Revue Française d'Hématologie 29 1987 109 114
19. Carlo-Stella C Cazzola M Gasner A Effects of recombinant α and γ interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-MK, BFU-E and CFU-GM) from patients with myelofibrosis and myeloid metaplasia Blood 70 1987 1014 1019
20. Cashman JD Eaves AC Raines EW Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β Blood 75 1990 96 101
21. Castro-Malaspina H Gay RE Thanwar SL Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders Blood 59 1982 1046 1056
22. Cervantes F Barosi G Demory J-L Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk-groups British Journal of Haematology 102 1998 684 690
23. Chaiter Y Brenner B Aghai E Tatarsky I High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel Leukemia and Lymphoma 7 1992 251 255
24. Dalley A Smith JM Reilly JT MacNeil S Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation British Journal of Haematology 93 1996 856 862
25. Dameshek W Some speculations on the myeloproliferative syndromes Blood 6 1951 372 375
26. 3 on the relationship between growth and differentiation in HL-60 cells Leukaemia Research 11 1987 191 196
27. Demory JL Dupriez B Fenaux P Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases Blood 72 1988 855 859
28. Den Ottolander GJ Velde J Brederoo P Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases British Journal of Haematology 42 1979 9 20
29. Dolan G Forrest PL Eastham JM Reilly JT Reduced platelet PDGF levels in idiopathic myelofibrosis British Journal of Haematology 78 1991 586 588
30. Donti E Tabilio A Bocchini F Partial trisomy 1q in idiopathic myelofibrosis Leukemia Research 14 1990 1035 1040
31. Dougan LE Matthews MLV Armstrong BK The effect of diagnostic review on the estimated incidence of lymphatic and haematopoietic neoplasms in Western Australia Cancer 48 1981 866 872
32. Dupriez B Morel P Demory Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system Blood 88 1996 1013 1018
33. Elliott MA Chen MG Silverstein MN Tefferi A Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia Blood 90 supplement 1 1997 346a
34. Fava RA Casey TT Wilcox J Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocytes and platelet α-granules Blood 76 1990 1946 1955
35. Frutchman SM Scigliano E Wassermann LR Recombinant erythropoietin (rHuEPO) can be effective in transfusion dependent myelofibrosis Blood 76 1990 271a
36. Gahrton G Friburg K Lindsten J Zech L Duplication of part of the long arm of chromosome 1 in myelofibrosis terminating in acute myeloblastic leukemia Hereditas 88 1978 1 5
37. Gaidano G Guerrasio A Serra A Mutations in the p53 and ras family genes are associated with tumour progression of bcr/abl negative chronic myeloproliferative disorders Leukemia 7 1993 946 953
38. Gardiner A Corcoran M Ibbotson R An analysis of chromosome 13q14 deletions in myelofibrosis using FISH and Southern-based hybridisation Blood 90 supplement 1 1997 292b
39. Gersuk G Carmel R Pattengale PK Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders Blood 14 1989 2330 2334
40. Gilbert HS Persistence of remission of myeloid metaplasia after treatment with recombinant interferon α-2b Blood 72 1988 200a
41. Gilbert HS Praloran V Stanley ER Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension Blood 74 1989 1231 1234
42. Guardiola P Esperou H Cazals-Hatem D Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia British Journal of Haematology 98 1997 1004 1009
43. (abstract) Guardiola P Anderson JE Bandini B Allogeneic bone marrow transplantation for agnogeneic myeloid metaplasia. An EBMT/F. Hutchinson CRC/SFGM collaborative study 24th Annual Meeting European Group for Blood and Marrow Transplantation Courmayeur, Italy, March 22–26 1998
44. Han ZC Brière J Nedellec G Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis European Journal of Haematology 40 1988 130 135
45. Heuck G Zwei Fälle von Leukämie mit eigenthümlichen Blut-resp. Knockenmarksbefund Virchows Archiv A 78 1879 475 496
46. Hibbin JAA Njoku OS Matutes E Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders British Journal of Haematology 57 1984 495 503
47. Hu H Benzene-associated myelofibrosis Annals of Internal Medicine 106 1987 171 173
48. Iványi JL Mahunka M Papp A Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system Haematologica 26 1994 75 86
49. Jack FR Smith SR Saunders PWG Idiopathic myelofibrosis: anaemia may respond to low-dose dexamethasone British Journal of Haematology 87 1994 876 884
50. Jacobson RJ Salo A Fialkow PJ Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis Blood 51 1978 189 194
51. Janssen JWG Steenvoorden ACM Lyons J Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodyplastic syndromes Proceedings of the National Academy of Sciences of the USA 84 1987 9228 9232
52. Jantunen E Hänninen A Naukkarinen A Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: a case report with review of the literature American Journal of Hematology 46 1994 218 224
53. Johnston JB Dalal BI Israels SJ Deposition of transforming growth factor-β in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-β by leukemic cells American Journal of Clinical Pathology 103 1995 574 582
54. Kahn A Bernard JF Cottreau D A deficient G-6-PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis Humangenetik 30 1975 41 46
55. Katoh O Kimura A Kuramoto A Platelet-derived growth factor is decreased in patients with myeloproliferative disorders American Journal of Hematology 27 1988 276 280
56. Katoh O Kimura A Itoh T Kutamoto A Platelet-derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders American Journal of Hematology 35 1990 145 150
57. Kimura A Nakata Y Katoh O Hyodo H c-kit point mutations in patients with myeloproliferative disorders Leukemia and Lymphoma 25 1997 281 287
58. Kreipe H Jaquet K Felgner J Clonal granulocytes and marrow cells in the cellular phase of agnogenic myeloid metaplasia Blood 78 1991 1814 1817
59. Leinweber C Order SE Calkins AR Whole-abdominal irradiation for the management of gastrointestinal and abdominal manifestations of agnosgenic myeloid metaplasia Cancer 68 1991 1251 1254
60. Lévy V Bourgarit A Delmer A Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases American Journal of Hematology 53 1996 239 241
61. Liu Y Corcoran M Rasol O The minimally deleted region in 13q can be defined within an area not larger than 10 kb Oncogene 15 1997 2463 2473
62. Lofvenberg E Wahlin A Roos G Ost A Reversal of myelofibrosis by hydroxyurea European Journal of Haematology 44 1990 33 38
63. López-Guillermo A Cervantes F Bruguera M Liver dysfunction following splenectomy in idiopathic myelofibrosis: a study of 10 patients Acta Haematologica 85 1991 184 188
64. Manoharan A Pitney WR Chemotherapy resolves symptoms and reverses bone marrow fibrosis in myelofibrosis Scandinavian Journal of Haematology 33 1984 453 459
65. Martyré MC Magdelenat H Bryckaert MC Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia British Journal of Haematology 77 1991 80 86
66. Martyré MC Le Bousee-Kerdiles MC Romquin N Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis British Journal of Haematology 97 1997 441 448
67. Mertens F Johansson B Heim S Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of literature Leukemia 5 1991 214 220
68. Mesa RA Tefferi A Jacobsen SJ The incidence and epidemiology of essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study Blood 90 supplement 1 1997 347a
69. Miller JB Testa JR Lindgren V Rowley JD The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis Cancer 55 1985 582 591
70. Mitelman F Catolog of Chromosome Aberrations in Cancer 5th edn 1994 Wiley New York
71. Mohr B Herrman R Hunh D Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis Acta Haematologica 90 1993 65 70
72. Moliterno AR Hankins WD Spivak JL Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera New England Journal of Medicine 338 1998 572 580
73. Morris CM Cochrane JM Benjes SM Molecular definition of interstitial deletions of chromosome 13 in leukaemic cells Genes, Chromosomes and Cancer 3 1991 455 460
74. Murate T Yamashita K Isogai C The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis British Journal of Haematology 99 1997 181 189
75. Pastore C Nomdedeu J Volpe G Genetic analysis of chromosomal 13 deletions in bcr/abl negative chronic myeloproliferative disorders Genes, Chromosomes and Cytogenetics 14 1995 106 111
76. Price F Bell H Spinal cord compression due to extramedullary hematopoiesis. Successful treatment in a patient with long standing myelofibrosis JAMA 253 1985 2876 2877
77. Rajantie J Sale GE Deeg HJ Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation Blood 67 1986 1693 1697
78. Rameshwar P Chang VT Gascón P Implications of CD44 in adhesion-mediated overproduction of TGF-β and IL-1 in monocytes from patients with bone marrow fibrosis British Journal of Haematology 93 1996 22 29
79. Reilly JT Pathogenesis of idiopathic myelofibrosis: present status and future directions British Journal of Haematology 88 1994 1 8
80. Reilly JT Idiopathic myelofibrosis: pathogenesis, natural history and management Blood Reviews 11 1997 233 242
81. Reilly JT Barnett D Dolan G Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis British Journal of Haematology 83 1993 58 62
82. Reilly JT Wilson G Barnett D Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis British Journal of Haematology 88 1994 575 581
83. Reilly JT Snowden JA Spearing RL Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases British Journal of Haematology 98 1997 96 102
84. Ritchie A Gotoh A Gaddy J Thrombopoietin upregulates the promoter conformation of p53 in a proliferative-independent manner coincident with a decreased expression of Bax: potential mechanisms for enhancing effects Blood 90 1997 4394 4402
85. Rozman C Giralt M Feliu E Life expectancy of patients with chronic nonleukemic myeloproliferative disorders Cancer 67 1991 2658 2663
86. Rupoli S Da Lio L Siati S Primary myelofibrosis: a detailed statistical analysis of the clinicopathogical variables influencing survival Annals of Hematology 68 1994 205 212
87. Siitonen T Savolainen E-R Koistinen P Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes Leukemia 8 1994 631 637
88. Siitonen T Zheng A Savolainen E-R Koistinen P Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders Leukemia Research 20 1996 187 195
89. Silverstein MN Agnogenic Myeloid Metaplasia 1975 Publishing Sciences Group Inc. Massachusetts
90. Silverstein MN Agnogeneic myeloid metaplasia Williams WJ Beutler E Erslev AJ Lichtman MA Haematology 1983 McGraw-Hill New York 214 218
91. Silverstein MN ReMine WH Splenectomy in myeloid metaplasia Blood 53 1979 515 518
92. Silverstein MN Petitt RM Solberg LA Anagrelide: a new drug for treating thrombocytosis New England Journal of Medicine 318 1988 1292 1294
93. Sivera P Cesano L Guerrasio A Clinical and haematological improvement induced by edidronate in a patient with idiopathic myelofibrosis and osteosclerosis British Journal of Haematology 86 1994 397 398
94. La Starza R Wlodarska I Aventin D Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies Blood 91 1998 231 237
95. Tefferi A Silverstein MN Recombinant human erythropoietin in patients with myelofibrosis with myeloid metaplasia British Journal of Haematology 86 1994 893 896
96. Tefferi A Silverstein MN Noël P Agnogenic myeloid metaplasia Seminars in Oncology 22 1995 327 333
97. Tefferi A Silverstein MN Li C-Y 2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia British Journal of Haematology 99 1997 352 357
98. Tefferi A Silverstein MN Plumhoff EA Suramin toxicity and efficacy in agnogenic myeloid metaplasia Journal of the National Cancer Institute 85 1993 1520 1522
99. Terui T Niitsu Y Mahara K The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis Blood 75 1990 1540 1548
100. Thiele J Kuemmel T Sander C Fischer R Ultrastructure of the bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). 1. Abnormalities of megakaryopoiesis and thrombocytes Journal of Submicroscopic Cytology and Pathology 23 1991 93 107
101. Thiele J Kvasnicka HM Fischer R Diehl V Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update Leukemia and Lymphoma 24 1997 463 481
102. Titius BR Thiele J Schaefer H Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages Acta Haematologica 91 1994 144 149
103. Trautmann U Rubbert A Gramatzki M Multiple chromosomal changes and karyotypic evolution in a patient with myelofibrosis Cancer Genetics and Cytogenetics 61 1992 6 10
104. Ulich TR del Castillo J Senaldi G Systematic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice Blood 87 1996 5006 5015
105. Varki A Lottenberg R Griffith R Reinhard E The syndrome of idiopathic myelofibrosis: a clinicopathologic review with emphasis on the prognostic variables predicting survival Medicine 62 1983 353 371
106. Visani G Finelli C Castelli U Myelofibrosis with myeloid metaplasia: clinical and hematological parameters predicting survival in a series of 133 patients British Journal of Hematology 75 1990 4 9
107. Wang JC Chen C Lou L-H Mora M Blood thrombopoietin, Il-6 and Il-11 levels in patients with agnogenic myeloid metaplasia Leukemia 11 1997 1827 1832
108. Wang JC Lang H-D Lichter S Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia British Journal of Haematology 80 1992 184 188
109. Whang-Peng J Lee E Knutsen T Cytogenetic studies in patients with myelofibrosis and myeloid metaplasia Leukemia Research 2 1978 41 56
110. Yan X-Q Lacey D Hill D A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand); reversal of disease by bone marrow transplantation Blood 88 1996 402 409
111. Yanagida M Ide Y Imai A The role of transforming growth factor-β in PEG-rHuMGDF-induced reversible myelofibrosis in rats British Journal of Haematology 99 1997 739 745
112. Yetgin S Ozsoylu S Myeloid metaplasia in vitamin D deficiency rickets Scandinavian Journal of Haematology 28 1982 180 185
113. Zanke B Squire J Griesser H A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1 Leukaemia 8 1994 236 244